SIC
ONEM

SJS Investment Consulting’s 1Life Healthcare ONEM Stock Holding History

SJS Investment Consulting’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14
Closed – – 1732
2022
Q3 		$0 Buy
+14
New +$220 ﹤0.01% 1688

Other funds holding ONEM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

SJS Investment Consulting's ONEM Position: Q4 2022 in Review

SJS Investment Consulting sold out of 1Life Healthcare (ONEM) in Q4 2022, closing a stake of 14 shares.

SJS Investment Consulting first reported a position in ONEM in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 230 funds tracked by Wall St. Rank hold ONEM as of Q4 2022.

  • SJS Investment Consulting reported no remaining 1Life Healthcare position as of Q4 2022 after selling out during the quarter.
  • SJS Investment Consulting sold 14 1Life Healthcare shares in Q4 2022.
  • SJS Investment Consulting first reported a position in 1Life Healthcare in Q3 2022 and held it in 1 quarter.
  • SJS Investment Consulting's 1Life Healthcare position peaked at $0 in Q3 2022.
  • 230 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2022.

Based on SJS Investment Consulting's 13F filing for Q4 2022, filed 23 Jan 2023.